Home pageSDZ • SWX
add
Sandoz
Chiusura precedente
57,70Â CHF
Intervallo giornaliero
57,46Â CHF - 57,92Â CHF
Intervallo annuale
26,25Â CHF - 59,86Â CHF
Cap di mercato
25,44Â Mld CHF
Volume medio
742,58K
Rapporto P/E
141,94
Dividendo/Prezzo
1,04%
Borsa valori principale
SWX
Notizie del mercato finanziario
Dati finanziari
Conto economico
Entrate
Utile netto
| (USD) | giu 2025info | Variazione Y/Y |
|---|---|---|
Entrate | 2,63Â Mld | 4,01% |
Spese di gestione | 904,50Â Mln | -11,67% |
Utile netto | 188,50Â Mln | 151,33% |
Margine di profitto netto | 7,16 | 141,89% |
Utili per azione | — | — |
EBITDA | 415,00Â Mln | 53,42% |
Aliquota fiscale effettiva | 25,20% | — |
Stato patrimoniale
Totale attivo
Totale passivo
| (USD) | giu 2025info | Variazione Y/Y |
|---|---|---|
Investimenti cash/breve termine | 1,39Â Mld | 98,15% |
Totale attivo | 21,61Â Mld | 11,86% |
Totale passivo | 12,79Â Mld | 16,79% |
Patrimonio netto totale | 8,82 Mld | — |
Azioni in circolazione | 432,00 Mln | — |
Prezzo/valore contabile | 2,83 | — |
Redditività dell'attivo | 3,48% | — |
Rendimento sul capitale | 5,18% | — |
Flusso di cassa
Flusso di cassa netto
| (USD) | giu 2025info | Variazione Y/Y |
|---|---|---|
Utile netto | 188,50Â Mln | 151,33% |
Liquidità di esercizio | 261,50 Mln | 128,38% |
Contanti da investimenti | -158,00Â Mln | 19,80% |
Contanti da finanziamenti | -74,00Â Mln | 35,09% |
Flusso di cassa netto | 99,00Â Mln | 148,53% |
Flusso di cassa libero | 151,94Â Mln | 47,69% |
Informazioni
Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz. Before this, the company existed as an independent pharmaceutical manufacturer until 1996, when it was merged with Ciba-Geigy to form Novartis. Prior to the merger, it specialized in medicines used in organ transplants, such as Sandimmune, and various antipsychotics and migraine medicines. Its headquarters were in Holzkirchen, Germany and after the spin-off from Novartis, the headquarters moved to Basel, Switzerland, with most of global functions operating from Holzkirchen in Germany, Prague in Czechia, and Barcelona in Spain. Sandoz is the global leader in generic pharmaceuticals and biosimilars. Wikipedia
Fondazione
1886
Sito web
Dipendenti
20.000